Clinical trials

  • LUNSEKIMIG for Asthma
  • everolimus for Kidney transplantation|NK-mediated kidney graft rejection
  • DRONABINOL for Chronic obstructive pulmonary disease
  • SEMAGLUTIDE for Resistant hypertension | Obesity
  • LEVOSIMENDAN for Cardiogenic shock
  • Lyophilized bacterial lysates of: Haemophilus influenzae, Streptococcus (diplococcus) pneumoniae, Klebsiella pneumoniae and ozaenae, Staphylococcus aureus, Streptococcus pyogenes and viridans, Moraxella (Branhamella/Neisseria) catarrhalis for Recurrent respiratory tract infections | Respiratory tract infections
  • VISUGROMAB for Muscle-invasive bladder cancer
  • POTASSIUM CANRENOATE, TROMETAMOL for Brain death (organ donors)
  • RAPCABTAGENE AUTOLEUCEL for Myasthenia gravis (treatment-resistant, generalized)
  • LITHIUM CARBONATE for TBR1-related neurocognitive disorder
  • IBUPROFEN for Acute myocarditis
  • ADS-019 for Myotonic dystrophy type 1